Latest filing published 01 Jul 2021 for Elevation Oncology, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Aisling Capital IV, LP: trading record in brief
This profile gathers the share dealings of Aisling Capital IV, LP across 3 companies, led by Elevation Oncology, Inc., Zosano Pharma Corp and Viracta Therapeutics, Inc. Over a trading history stretching from 11 April 2019 to 29 June 2021, the count stands at 6 filings.
On the market, this insider has only ever bought: 2 purchases, €3.9M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. In 2021 alone, the filings show 1 purchase and no sales.
On 1 July 2021 came the latest disclosure, an open-market purchase for €2.5M in Elevation Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Aisling Capital IV, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,893,232 shares0Common StockSEC:0001209191-21-044561:0
1 of 1 declaration
